<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38787262</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">410</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens13050410</ELocationID><Abstract><AbstractText>Enteroviruses (EV) are important pathogens causing human disease with various clinical manifestations. To date, treatment of enteroviral infections is mainly supportive since no vaccination or antiviral drugs are approved for their prevention or treatment. Here, we describe the antiviral properties and mechanisms of action of leucoverdazyls-novel heterocyclic compounds with antioxidant potential. The lead compound, <b>1a</b>, demonstrated low cytotoxicity along with high antioxidant and virus-inhibiting activity. A viral strain resistant to <b>1a</b> was selected, and the development of resistance was shown to be accompanied by mutation of virus-specific non-structural protein 2C. This resistant virus had lower fitness when grown in cell culture. Taken together, our results demonstrate high antiviral potential of leucoverdazyls as novel inhibitors of enterovirus replication and support previous evidence of an important role of 2C proteins in EV replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Volobueva</LastName><ForeName>Alexandrina S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedorchenko</LastName><ForeName>Tatyana G</ForeName><Initials>TG</Initials><Identifier Source="ORCID">0000-0002-0538-5638</Identifier><AffiliationInfo><Affiliation>Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, 22/20 S. Kovalevskoi St., Yekaterinburg 620108, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipunova</LastName><ForeName>Galina N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, 22/20 S. Kovalevskoi St., Yekaterinburg 620108, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valova</LastName><ForeName>Marina S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, 22/20 S. Kovalevskoi St., Yekaterinburg 620108, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbarzaglia</LastName><ForeName>Valeriya A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gladkikh</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0001-6759-1907</Identifier><AffiliationInfo><Affiliation>St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaeva</LastName><ForeName>Olga I</ForeName><Initials>OI</Initials><Identifier Source="ORCID">0000-0002-7699-5097</Identifier><AffiliationInfo><Affiliation>St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolstykh</LastName><ForeName>Natalia A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorshkov</LastName><ForeName>Andrey N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Smorodintsev Influenza Research Institute, 15/17 Prof. Popova St., St. Petersburg 197376, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarubaev</LastName><ForeName>Vladimir V</ForeName><Initials>VV</Initials><Identifier Source="ORCID">0000-0002-5224-3771</Identifier><AffiliationInfo><Affiliation>St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>АААА-А21-121030200272-6</GrantID><Agency>Ural Branch of the Russian Academy of Sciences</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2C protein</Keyword><Keyword MajorTopicYN="N">antioxidant</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">enteroviruses</Keyword><Keyword MajorTopicYN="N">leucoverdazyls</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>9</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38787262</ArticleId><ArticleId IdType="pmc">PMC11123948</ArticleId><ArticleId IdType="doi">10.3390/pathogens13050410</ArticleId><ArticleId IdType="pii">pathogens13050410</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Simmonds P., Gorbalenya A.E., Harvala H., Hovi T., Knowles N.J., Lindberg A.M., Oberste M.S., Palmenberg A.C., Reuter G., Skern T., et al. Recommendations for the nomenclature of enteroviruses and rhinoviruses. Arch. Virol. 2020;165:793–797. doi: 10.1007/s00705-019-04520-6. Erratum in Arch. Virol. 2020, 165, 1515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-019-04520-6</ArticleId><ArticleId IdType="pmc">PMC7024059</ArticleId><ArticleId IdType="pubmed">31980941</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo D., Krogstad P. Enteroviruses in the early 21st century: New manifestations and challenges. Curr. Opin. Pediatr. 2016;28:107–113. doi: 10.1097/MOP.0000000000000303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000303</ArticleId><ArticleId IdType="pmc">PMC4750492</ArticleId><ArticleId IdType="pubmed">26709690</ArticleId></ArticleIdList></Reference><Reference><Citation>Genoni A., Canducci F., Rossi A., Broccolo F., Chumakov K., Bono G., Salerno-Uriarte J., Salvatoni A., Pugliese A., Toniolo A. Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach. Sci. Rep. 2017;7:5013. doi: 10.1038/s41598-017-04993-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04993-y</ArticleId><ArticleId IdType="pmc">PMC5504018</ArticleId><ArticleId IdType="pubmed">28694527</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M.P., Alidjinou E.K., Hober D. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2022;18:503–516. doi: 10.1038/s41574-022-00688-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N.M. Persistent Enterovirus Infection: Little Deletions, Long Infections. Vaccines. 2022;10:770. doi: 10.3390/vaccines10050770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050770</ArticleId><ArticleId IdType="pmc">PMC9143164</ArticleId><ArticleId IdType="pubmed">35632526</ArticleId></ArticleIdList></Reference><Reference><Citation>Légeret C., Furlano R. Oral ulcers in children—A clinical narrative overview. Ital. J. Pediatr. 2021;47:144. doi: 10.1186/s13052-021-01097-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01097-2</ArticleId><ArticleId IdType="pmc">PMC8246667</ArticleId><ArticleId IdType="pubmed">34193212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zhang Y., Li H., Liu L. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines. Int. J. Mol. Sci. 2023;24:169. doi: 10.3390/ijms24010169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010169</ArticleId><ArticleId IdType="pmc">PMC9820767</ArticleId><ArticleId IdType="pubmed">36613612</ArticleId></ArticleIdList></Reference><Reference><Citation>Frydenberg A., Starr M. Hand, foot and mouth disease. Aust. Fam. Physician. 2003;32:594–595.</Citation><ArticleIdList><ArticleId IdType="pubmed">12973865</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazmi A., Nekoua M.P., Mercier A., Vergez I., Sane F., Alidjinou E.K., Hober D. Combating coxsackievirus B infections. Rev. Med. Virol. 2022;33:e2406. doi: 10.1002/rmv.2406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2406</ArticleId><ArticleId IdType="pubmed">36371612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay A.S., Garon J., Seib K., Orenstein W.A. Polio vaccination: Past, present and future. Future Microbiol. 2015;10:791–808. doi: 10.2217/fmb.15.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.19</ArticleId><ArticleId IdType="pubmed">25824845</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov K., Ehrenfeld E., Agol V.I., Wimmer E. Polio eradication at the crossroads. Lancet Glob. Health. 2021;9:e1172–e1175. doi: 10.1016/S2214-109X(21)00205-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00205-9</ArticleId><ArticleId IdType="pubmed">34118192</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.L., Shih S.R., Tolbert B.S., Brewer G. Enterovirus A71 Vaccines. Vaccines. 2021;9:199. doi: 10.3390/vaccines9030199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030199</ArticleId><ArticleId IdType="pmc">PMC7997495</ArticleId><ArticleId IdType="pubmed">33673595</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J.R.P.M., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4. Erratum in Nat. Rev. Microbiol. 2018, 16, 391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Sun D., Guo J., Elgner F., Wang M., Hildt E., Cheng A. Multifunctionality of structural proteins in the enterovirus life cycle. Future Microbiol. 2019;14:1147–1157. doi: 10.2217/fmb-2019-0127.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2019-0127</ArticleId><ArticleId IdType="pubmed">31368347</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Lyoo H., van der Schaar H.M., Strating J.R., van Kuppeveld F.J. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. Curr. Opin. Virol. 2017;24:1–8. doi: 10.1016/j.coviro.2017.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.009</ArticleId><ArticleId IdType="pmc">PMC7172203</ArticleId><ArticleId IdType="pubmed">28411509</ArticleId></ArticleIdList></Reference><Reference><Citation>Laajala M., Reshamwala D., Marjomäki V. Therapeutic targets for enterovirus infections. Expert. Opin. Ther. Targets. 2020;24:745–757. doi: 10.1080/14728222.2020.1784141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2020.1784141</ArticleId><ArticleId IdType="pubmed">32552314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tammaro C., Guida M., Appetecchia F., Biava M., Consalvi S., Poce G. Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances. Pharmaceuticals. 2023;16:203. doi: 10.3390/ph16020203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16020203</ArticleId><ArticleId IdType="pmc">PMC9966857</ArticleId><ArticleId IdType="pubmed">37259352</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao L., Lemoff A., Wang G., Zarek C., Lowe A., Yan N., Reese T.A. Reactive oxygen species oxidize STING and suppress interferon production. eLife. 2020;9:e57837. doi: 10.7554/eLife.57837.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57837</ArticleId><ArticleId IdType="pmc">PMC7473769</ArticleId><ArticleId IdType="pubmed">32886065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Cao Z., Wang Z., Guo J., Wen J. Reactive oxygen species associated immunoregulation post influenza virus infection. Front. Immunol. 2022;13:927593. doi: 10.3389/fimmu.2022.927593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.927593</ArticleId><ArticleId IdType="pmc">PMC9373727</ArticleId><ArticleId IdType="pubmed">35967412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.L., Weng S.F., Kuo C.H., Ho H.Y. Enterovirus 71 induces mitochondrial reactive oxygen species generation that is required for efficient replication. PLoS ONE. 2014;9:e113234. doi: 10.1371/journal.pone.0113234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113234</ArticleId><ArticleId IdType="pmc">PMC4234665</ArticleId><ArticleId IdType="pubmed">25401329</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.L., Wu C.H., Chien K.Y., Lai C.H., Li G.J., Liu Y.Y., Lin G., Ho H.Y. Enteroviral 2B Interacts with VDAC3 to Regulate Reactive Oxygen Species Generation That Is Essential to Viral Replication. Viruses. 2022;14:1717. doi: 10.3390/v14081717.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081717</ArticleId><ArticleId IdType="pmc">PMC9416218</ArticleId><ArticleId IdType="pubmed">36016340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander W.J., Fourie C., Sabiu S., O’Neill F.H., Pohl C.H., O’Neill H.G. Reactive oxygen species as potential antiviral targets. Rev. Med. Virol. 2022;32:e2240. doi: 10.1002/rmv.2240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2240</ArticleId><ArticleId IdType="pubmed">33949029</ArticleId></ArticleIdList></Reference><Reference><Citation>Filardo S., Di Pietro M., Mastromarino P., Sessa R. Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacol. Ther. 2020;214:107613. doi: 10.1016/j.pharmthera.2020.107613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107613</ArticleId><ArticleId IdType="pubmed">32562826</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Petrillo A., Orrù G., Fais A., Fantini M.C. Quercetin and its derivates as antiviral potentials: A comprehensive review. Phytother. Res. 2022;36:266–278. doi: 10.1002/ptr.7309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7309</ArticleId><ArticleId IdType="pmc">PMC8662201</ArticleId><ArticleId IdType="pubmed">34709675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhao S., Chen Y., Wang Y., Wang T., Wo X., Dong Y., Zhang J., Xu W., Qu C., et al. N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication and inflammatory response. Antivir. Res. 2020;179:104699. doi: 10.1016/j.antiviral.2019.104699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.104699</ArticleId><ArticleId IdType="pubmed">31883926</ArticleId></ArticleIdList></Reference><Reference><Citation>Volobueva A.S., Zarubaev V.V., Fedorchenko T.G., Lipunova G.N., Tungusov V.N., Chupakhin O.N. Antiviral properties of verdazyls and leucoverdazyls and their activity against group B enteroviruses. Russ. J. Infect. Immun. 2023;13:107–118. doi: 10.15789/2220-7619-VAL-2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.15789/2220-7619-VAL-2065</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorchenko T.G., Lipunova G.N., Shchepochkin A.V., Valova M.S., Tsmokalyuk A.N., Slepukhin P.A., Chupakhin O.N. Synthesis and Spectral, Electrochemical, and Antioxidant Properties of 2-(5-Aryl-6-R-3-phenyl-5,6-dihydro-4H-1,2,4,5-tetrazin-1-yl)-1,3-benzothiazole. Russ. J. Org. Chem. 2020;56:38–48. doi: 10.1134/S1070428020010078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S1070428020010078</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) Manual for the Virological Investigation of Polio. 4th ed. WHO; Geneva, Switzerland: 2004. pp. 1–112.</Citation></Reference><Reference><Citation>Nix W.A., Oberste M.S., Pallansch M.A. Sensitive, Seminested PCR Amplification of VP1 Sequences for Direct Identification of All Enterovirus Serotypes from Original Clinical Specimens. J. Clin. Microbiol. 2006;44:2698–2704. doi: 10.1128/JCM.00542-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(83)90303-4</ArticleId><ArticleId IdType="pubmed">6606682</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetnev A.A., Volobueva A.S., Panova V.A., Zarubaev V.V., Baykov S.V. Design of 4-Substituted Sulfonamidobenzoic Acid De-rivatives Targeting Coxsackievirus B3. Life. 2022;12:1832. doi: 10.3390/life12111832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12111832</ArticleId><ArticleId IdType="pmc">PMC9694965</ArticleId><ArticleId IdType="pubmed">36362987</ArticleId></ArticleIdList></Reference><Reference><Citation>Daelemans D., Pauwels R., De Clercq E., Pannecouque C. A time-of-drug addition approach to target identification of antiviral compounds. Nat. Protoc. 2011;6:925–933. doi: 10.1038/nprot.2011.330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.330</ArticleId><ArticleId IdType="pmc">PMC7086561</ArticleId><ArticleId IdType="pubmed">21637207</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Li Z., Xiang F., Li F., Zheng Y., Wang G. The whole genome sequence of coxsackievirus B3 MKP strain leading to myocarditis its molecular phylogenetic analysis. Virol. J. 2014;11:33. doi: 10.1186/1743-422X-11-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-33</ArticleId><ArticleId IdType="pmc">PMC3996064</ArticleId><ArticleId IdType="pubmed">24555514</ArticleId></ArticleIdList></Reference><Reference><Citation>Okonechnikov K., Golosova O., Fursov M., UGENE team Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics. 2012;28:1166–1167. doi: 10.1093/bioinformatics/bts091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts091</ArticleId><ArticleId IdType="pubmed">22368248</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 12 February 2022)].  Available online:  https://web.expasy.org/translate/</Citation></Reference><Reference><Citation> [(accessed on 12 February 2022)].  Available online:  http://hexserver.loria.fr/</Citation></Reference><Reference><Citation>Schmidtke M., Hammerschmidt E., Schüler S., Zell R., Birch-Hirschfeld E., Makarov V.A., Riabova O.B., Wutzler P. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: Antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. J. Antimicrob. Chemother. 2005;56:648–656. doi: 10.1093/jac/dki263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dki263</ArticleId><ArticleId IdType="pubmed">16150864</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X., Wan Z., Li Y., Hu Y., Jin X., Zhang C. National Epidemiology and Evolutionary History of Four Hand, Foot and Mouth Disease-Related Enteroviruses in China from 2008 to 2016. Virol. Sin. 2020;35:21–33. doi: 10.1007/s12250-019-00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00169-2</ArticleId><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Z.C., Kou Z.Q., Bai Y.J., Cong X., Wang L.H., Li C., Zhao L., Yu X.J., Wang Z.Y., Wen H.L. Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland China. Viruses. 2015;7:6400–6411. doi: 10.3390/v7122947.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122947</ArticleId><ArticleId IdType="pmc">PMC4690870</ArticleId><ArticleId IdType="pubmed">26690202</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreoni A.R., Colton A.S. Coxsackievirus B5 associated with hand-foot-mouth disease in a healthy adult. JAAD Case Rep. 2017;3:165–168. doi: 10.1016/j.jdcr.2017.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdcr.2017.01.026</ArticleId><ArticleId IdType="pmc">PMC5376252</ArticleId><ArticleId IdType="pubmed">28413820</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton D.J., Flanegan J.B. Synchronous replication of poliovirus RNA: Initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J. Virol. 1997;71:8482–8489. doi: 10.1128/JVI.71.11.8482-8489.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.11.8482-8489.1997</ArticleId><ArticleId IdType="pmc">PMC192311</ArticleId><ArticleId IdType="pubmed">9343205</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmikangas S., Laiho J.E., Kalander K., Laajala M., Honkimaa A., Shanina I., Oikarinen S., Horwitz M.S., Hyöty H., Marjomäki V. Detection of Viral-RNA and +RNA strands in Enterovirus-infected cells and tissues. Microorganisms. 2020;8:1928. doi: 10.3390/microorganisms8121928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8121928</ArticleId><ArticleId IdType="pmc">PMC7761939</ArticleId><ArticleId IdType="pubmed">33291747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wang M., Cheng A., Wen X., Ou X., Mao S., Gao Q., Sun D., Jia R., Yang Q., et al. Enterovirus Replication Organelles and Inhibitors of Their Formation. Front. Microbiol. 2020;11:1817. doi: 10.3389/fmicb.2020.01817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01817</ArticleId><ArticleId IdType="pmc">PMC7468505</ArticleId><ArticleId IdType="pubmed">32973693</ArticleId></ArticleIdList></Reference><Reference><Citation>Domanska A., Guryanov S., Butcher S.J. A comparative analysis of parechovirus protein structures with other picornaviruses. Open Biol. 2021;11:210008. doi: 10.1098/rsob.210008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.210008</ArticleId><ArticleId IdType="pmc">PMC8316810</ArticleId><ArticleId IdType="pubmed">34315275</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.C., Chathuranga K., Lee J.S. Intracellular sensing of viral genomes and viral evasion. Exp. Mol. Med. 2019;51:1–13. doi: 10.1038/s12276-019-0299-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0299-y</ArticleId><ArticleId IdType="pmc">PMC6906418</ArticleId><ArticleId IdType="pubmed">31827068</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov G.A. Dynamic lipid landscape of picornavirus replication organelles. Curr. Opin. Virol. 2016;19:1–6. doi: 10.1016/j.coviro.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC9004531</ArticleId><ArticleId IdType="pubmed">27240115</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G., Melia C.E., Snijder E.J., Bárcena M. Double-Membrane Vesicles as Platforms for Viral Replication. Trends Microbiol. 2020;28:1022–1033. doi: 10.1016/j.tim.2020.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7289118</ArticleId><ArticleId IdType="pubmed">32536523</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai M., De Carli A., Filipponi C., Iacono E., La Rocca V., Lottini G., Piazza C.R., Quaranta P., Sidoti M., Pistello M., et al. Lipid balance remodelling by human positive-strand RNA viruses and the contribution of lysosomes. Antivir. Res. 2022;206:105398. doi: 10.1016/j.antiviral.2022.105398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105398</ArticleId><ArticleId IdType="pubmed">35985406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadare G., Haenni A.L. Virus-encoded RNA helicases. J. Virol. 1997;71:2583–2590. doi: 10.1128/jvi.71.4.2583-2590.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.4.2583-2590.1997</ArticleId><ArticleId IdType="pmc">PMC191378</ArticleId><ArticleId IdType="pubmed">9060609</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.H., Wang K., Zhao K., Hua S.C., Du J. The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C. Front. Microbiol. 2020;11:615965. doi: 10.3389/fmicb.2020.615965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.615965</ArticleId><ArticleId IdType="pmc">PMC7767853</ArticleId><ArticleId IdType="pubmed">33381104</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton M.R., Dillingham M.S., Wigley D.B. Structure and mechanism of helicases and nucleic acid translocases. Annu. Rev. Biochem. 2007;76:23–50. doi: 10.1146/annurev.biochem.76.052305.115300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.76.052305.115300</ArticleId><ArticleId IdType="pubmed">17506634</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Wang P., Wang G.C., Yang J., Sun X., Wu W., Qiu Y., Shu T., Zhao X., Yin L., et al. Human Enterovirus Nonstructural Protein 2CATPase Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone. PLoS Pathog. 2015;11:e1005067. doi: 10.1371/journal.ppat.1005067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005067</ArticleId><ArticleId IdType="pmc">PMC4517893</ArticleId><ArticleId IdType="pubmed">26218680</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Li Z., Cui S. Picornaviral 2C proteins: A unique ATPase family critical in virus replication. Enzymes. 2021;49:235–264. doi: 10.1016/bs.enz.2021.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.enz.2021.06.008</ArticleId><ArticleId IdType="pubmed">34696834</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Wojdyla J.A., Colasanti O., Li Z., Qin B., Wang M., Lohmann V., Cui S. Biochemical structural characterization of hepatitis A virus 2C reveals an unusual ribonuclease activity on single-stranded, R.N.A. Nucleic Acids Res. 2022;50:9470–9489. doi: 10.1093/nar/gkac671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac671</ArticleId><ArticleId IdType="pmc">PMC9458454</ArticleId><ArticleId IdType="pubmed">35947700</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Zheng Z., Liu Y., Zhang Z., Liu Q., Meng J., Ke X., Hu Q., Wang H. 2C Proteins of Enteroviruses Suppress IKKβ Phosphorylation by Recruiting Protein Phosphatase 1. J. Virol. 2016;90:5141–5151. doi: 10.1128/JVI.03021-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03021-15</ArticleId><ArticleId IdType="pmc">PMC4859720</ArticleId><ArticleId IdType="pubmed">26962213</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H., Yin P., Yang X., Zhang L., Jin Q., Zhu G. Enterovirus 71 2c Protein Inhibits NF-KappaB Activation by Binding to RelA(P65) Sci. Rep. 2015;5:14302. doi: 10.1038/srep14302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14302</ArticleId><ArticleId IdType="pmc">PMC4585786</ArticleId><ArticleId IdType="pubmed">26394554</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Fan H., Song Z., Liu X., Bai J., Jiang P. Encephalomyocarditis Virus 2C Protein Antagonizes Interferon-Beta Signaling Pathway through Interaction with MDA5. Antivir. Res. 2019;161:70–84. doi: 10.1016/j.antiviral.2018.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.10.010</ArticleId><ArticleId IdType="pubmed">30312637</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Ning S., Su X., Liu X., Wang H., Liu Y., Zheng W., Zheng B., Yu X.F., Zhang W. Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor, A.3.G. Nucleic Acids Res. 2018;46:11514–11527. doi: 10.1093/nar/gky840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky840</ArticleId><ArticleId IdType="pmc">PMC6265463</ArticleId><ArticleId IdType="pubmed">30247716</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H., Tian J., Qin B., Wojdyla J.A., Wang B., Zhao Z., Wang M., Cui S. Crystal structure of 2C helicase from enterovirus 71. Sci. Adv. 2017;3:e1602573. doi: 10.1126/sciadv.1602573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1602573</ArticleId><ArticleId IdType="pmc">PMC5409451</ArticleId><ArticleId IdType="pubmed">28508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H., Tian J., Zhang C., Qin B., Cui S. Crystal structure of a soluble fragment of poliovirus 2CATPase. PLoS Pathog. 2018;14:e1007304. doi: 10.1371/journal.ppat.1007304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007304</ArticleId><ArticleId IdType="pmc">PMC6166989</ArticleId><ArticleId IdType="pubmed">30231078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurdiss D.L., El Kazzi P., Bauer L., Papageorgiou N., Ferron F.P., Donselaar T., van Vliet A.L.W., Shamorkina T.M., Snijder J., Canard B., et al. Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex. Sci. Adv. 2022;8:eabj7615. doi: 10.1126/sciadv.abj7615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abj7615</ArticleId><ArticleId IdType="pmc">PMC8730599</ArticleId><ArticleId IdType="pubmed">34985963</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P., Kandiah E., Effantin G., Steven A.C., Ehrenfeld E. Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. J. Biol. Chem. 2009;284:22012–22021. doi: 10.1074/jbc.M109.031807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031807</ArticleId><ArticleId IdType="pmc">PMC2755925</ArticleId><ArticleId IdType="pubmed">19520852</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney T.R., Cisnetto V., Bose D., Bailey M., Wilson J.R., Zhang X., Belsham G.J., Curry S. Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism. J. Biol. Chem. 2010;285:24347–24359. doi: 10.1074/jbc.M110.129940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.129940</ArticleId><ArticleId IdType="pmc">PMC2915670</ArticleId><ArticleId IdType="pubmed">20507978</ArticleId></ArticleIdList></Reference><Reference><Citation>Papageorgiou N., Coutard B., Lantez V., Gautron E., Chauvet O., Baronti C., Norder H., de Lamballerie X., Heresanu V., Ferté N., et al. The 2C putative helicase of echovirus 30 adopts a hexameric ring-shaped structure. Pt 10Acta Crystallogr. D Biol. Crystallogr. 2010;66:1116–1120. doi: 10.1107/S090744491002809X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S090744491002809X</ArticleId><ArticleId IdType="pubmed">20944244</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M., Hadaschik D., Zimmermann H., Eggers H.J., Nelsen-Salz B. 2000 The picornavirus replication inhibitors, H.B.B.; guanidine in the echovirus-9 system: The significance of viral protein, 2.C. Pt 4J. Gen. Virol. 2000;81:895–901. doi: 10.1099/0022-1317-81-4-895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-4-895</ArticleId><ArticleId IdType="pubmed">10725414</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma A.M., Heggermont W., Lanke K., Coutard B., Bergmann M., Monforte A.M., Canard B., De Clercq E., Chimirri A., Pürstinger G., et al. The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein, 2.C. J. Virol. 2008;82:4720–4730. doi: 10.1128/JVI.01338-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01338-07</ArticleId><ArticleId IdType="pmc">PMC2346740</ArticleId><ArticleId IdType="pubmed">18337578</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H., Agoh M., Agoh Y., Yoshida H., Yoshii K., Yoneyama T., Hagiwara A., Miyamura T. Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. J. Virol. 2000;74:4146–4154. doi: 10.1128/jvi.74.9.4146-4154.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.9.4146-4154.2000</ArticleId><ArticleId IdType="pmc">PMC111929</ArticleId><ArticleId IdType="pubmed">10756027</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain S.K., Panda S., Sahu B.P., Sarangi R. Activation of Host Cellular Signaling and Mechanism of Enterovirus 71 Viral Proteins Associated with Hand, Foot and Mouth Disease. Viruses. 2022;14:2190. doi: 10.3390/v14102190.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102190</ArticleId><ArticleId IdType="pmc">PMC9609926</ArticleId><ArticleId IdType="pubmed">36298746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.F., Yang S.Y., Wu B.W., Jheng J.R., Chen Y.L., Shih C.H., Lin K.H., Lai H.C., Tang P., Horng J.T. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J. Biol. Chem. 2007;282:5888–5898. doi: 10.1074/jbc.M611145200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611145200</ArticleId><ArticleId IdType="pubmed">17182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Laufman O., Perrino J., Andino R. Viral Generated Inter-Organelle Contacts Redirect Lipid Flux for Genome Replication. Cell. 2019;178:275–289.e16. doi: 10.1016/j.cell.2019.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.030</ArticleId><ArticleId IdType="pmc">PMC7077330</ArticleId><ArticleId IdType="pubmed">31204099</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>